Follow
Pierluigi Di Chiaro
Pierluigi Di Chiaro
European Institute of Oncology (IEO) - Milan
Verified email at ieo.it
Title
Cited by
Cited by
Year
Identification of noncanonical Wnt receptors required for Wnt-3a-induced early differentiation of human neural stem cells
N Bengoa-Vergniory, I Gorroño-Etxebarria, I López-Sánchez, M Marra, ...
Molecular Neurobiology 54, 6213-6224, 2017
202017
Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells
G Alfarano, M Audano, P Di Chiaro, C Balestrieri, M Milan, S Polletti, ...
Gut 72 (1), 109-128, 2023
42023
Coexisting morpho-biotypes unveil the regulatory bases of phenotypic plasticity in pancreatic ductal adenocarcinoma
P Di Chiaro, L Nacci, S Brandini, S Polletti, B Donati, F Gualdrini, G Frige, ...
bioRxiv, 2022.12. 12.520054, 2022
32022
The landscape of cancer-rewired GPCR signaling axes
C Arora, M Matic, L Bisceglia, P Di Chiaro, NDO Rosa, F Carli, L Clubb, ...
Cell Genomics 4 (5), 2024
22024
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
P Di Chiaro, L Nacci, F Arco, S Brandini, S Polletti, A Palamidessi, ...
Cancer Cell 42 (4), 662-681. e10, 2024
12024
Native extracellular matrix probes to target patient-and tissue-specific cell–microenvironment interactions by force spectroscopy
H Holuigue, L Nacci, P Di Chiaro, M Chighizola, I Locatelli, C Schulte, ...
Nanoscale 15 (37), 15382-15395, 2023
12023
Learning and actioning general principles of cancer cell drug sensitivity
F Carli, P Di Chiaro, M Morelli, C Arora, L Bisceglia, N De Oliveira Rosa, ...
2024
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer
A Cortesi, F Gandolfi, F Arco, P Di Chiaro, E Valli, S Polletti, R Noberini, ...
Science Advances 10 (13), eadk5386, 2024
2024
Abstract A092: Exploiting the neural-like properties of a new pancreatic cancer morpho-biotype for the development of a combinatorial treatment targeting tumor heterogeneity
GR Diaferia, P Di Chiaro, F Fiumani, L Nacci, A Zerbi, P Spaggiari, ...
Cancer Research 84 (2_Supplement), A092-A092, 2024
2024
Acetyl-CoA production by Mediator-bound 2-ketoacid dehydrogenases boosts de novo histone acetylation and is regulated by nitric oxide
M Russo, F Gualdrini, V Vallelonga, E Prosperini, R Noberini, S Pedretti, ...
Molecular Cell, 2024
2024
Learning and actioning general principles of cancer cell drug sensitivity
F Raimondi, P Di Chiaro, M Morelli, C Arora, L Bisceglia, ...
bioRxiv, 2024.03. 28.586783, 2024
2024
Molecular characterization of cellular heterogeneity in pancreatic ductal adenocarcinoma by transcriptome profiling
P Di Chiaro, S Brandini, G Diaferia, G Natoli
Pancreatology 21, S74, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–12